{"id":42735,"date":"2015-09-17T11:25:58","date_gmt":"2015-09-17T16:25:58","guid":{"rendered":"https:\/\/content.findlaw-admin.com\/ability-legal\/contracts\/uncategorized\/research-and-development-services-agreement-bio-technology2.html"},"modified":"2015-09-17T11:25:58","modified_gmt":"2015-09-17T16:25:58","slug":"research-and-development-services-agreement-bio-technology2","status":"publish","type":"corporate_contracts","link":"https:\/\/corporate.findlaw.com\/contracts\/operations\/research-and-development-services-agreement-bio-technology2.html","title":{"rendered":"Research and Development Services Agreement &#8211; Bio-Technology General Corp. and Bio-Technology General (Israel) Ltd."},"content":{"rendered":"<pre>\n                        AMENDED AND RESTATED RESEARCH AND\n                         DEVELOPMENT SERVICES AGREEMENT\n\n     THIS AGREEMENT, made and entered into as of this 28th day of December,\n1995, by and between BIO-TECHNOLOGY GENERAL CORP., a Delaware corporation ('BTG\nU.S.'), and BIO-TECHNOLOGY GENERAL (ISRAEL) LTD., an Israeli corporation ('BTG\nISRAEL').\n\n                              W I T N E S S E T H :\n\n     WHEREAS, BTG ISRAEL has experience in the research and development of\ngenetically engineered and other products and has the facilities, equipment and\nemployees that will permit it to carry out research and development activities\non behalf of BTG U.S.; and\n\n     WHEREAS, pursuant to a Research and Development Agreement dated as of May\n9, 1983, BTG U.S. has engaged BTG ISRAEL to render research and development\nservices to BTG U.S. in connection with BTG U.S.' research and development\nactivities, and BTG ISRAEL is willing to provide such services; and\n\n     WHEREAS, from time to time BTG U.S. and BTG ISRAEL have modified the terms\nunder which BTG ISRAEL provides research and development services to BTG U.S.;\nand\n\n     WHEREAS, BTG U.S. and BTG ISRAEL desire to amend and restate the terms\nunder which BTG ISRAEL will continue to provide research and development\nservices to BTG U.S.\n\n     NOW, THEREFORE, in consideration of the foregoing and for other good and\nvaluable consideration, the receipt and sufficiency of which are hereby\nacknowledged, the parties hereto hereby agree as follows:\n\n     1. Definitions. The following terms used in this Agreement shall have the\nmeanings set forth below:\n\n     1.1. 'Affiliate' shall mean an entity or person that directly, or\nindirectly through one or more intermediaries, controls, is controlled by, or is\nunder common control with, BTG U.S. For this purpose 'control' means the direct\nor indirect beneficial ownership of fifty percent (50%) or more of an entity's\nvoting stock or equity.\n\n     1.2. 'Chief Scientist' shall mean the office of the Chief Scientist of the\nState of Israel or any successor entity.\n\n     1.3. 'Principal Investigators' shall mean those scientists and technicians\nat Research Institutions who engage or participate in the conduct or supervision\nof a Sponsored Research Program.\n\n\n\n     1.4. 'Product' shall mean each and every product which embodies or is\nmanufactured by the use of, or which contains components which embody or are\nproduced by, the Technology.\n\n     1.5. 'Reimbursable Costs' shall mean all direct and indirect costs\n(including without limitation an allocable share of BTG ISRAEL's administrative\nexpenses) incurred by BTG ISRAEL in conducting the Sponsored Research Program or\nin providing technical assistance pursuant to Section 4 hereof, all as\ndetermined in accordance with United States generally accepted accounting\nprinciples. Such costs shall include, without limitation, salaries and wages,\npayroll taxes, contract labor, fringe benefits, facilities (including leasehold\nimprovements) and equipment repair and maintenance expenses, recruitment and\nrelocation expenses, communication expense, supplies, development and prototype\nmaterials, freight and transportation, training, education, travel expenses,\ndata processing costs, license fees, insurance, professional or other outside\npurchased services (including, without limitation, services performed by the\nPrincipal Investigators), depreciation and amortization of, and financing\ncharges for, capital acquisitions made on or after January 1, 1994, sales and\nuse taxes, and periodic lease payments under capital or financing leases of\nassets acquired by BTG ISRAEL or any Research Institution for use in conducting\nthe Sponsored Research Program. Such costs shall not include any exchange losses\nincurred as a result of any fluctuation in the rate of exchange between the\nIsrael Shekel and the U.S. dollar. BTG ISRAEL shall document the allocation of\nindirect costs, which allocations shall be submitted to BTG U.S. for its review\nand approval, which approval shall not be unreasonably withheld. Such allocation\nof indirect costs shall be reviewed by the parties in December of each year to\ndetermine whether such allocation should be revised for the next fiscal year.\nNotwithstanding the foregoing, Reimbursable Costs shall not include the direct\nand indirect costs of the Sponsored Research Program which are funded by the\nChief Scientist unless and until BTG ISRAEL is obligated to reimburse the Chief\nScientist for such funding, in which event Reimbursable Costs shall include the\namounts due the Chief Scientist in respect of such Sponsored Research Program,\nup to 100% of the amount of the Sponsored Research Program funded by the Chief\nScientist (denominated in U.S. Dollars). All third party costs shall be charged\nto BTG U.S. in an amount equal to the payments made by BTG ISRAEL to any such\nthird party in respect of the research and development.\n\n     1.6. 'Research Institutions' shall mean those universities, research\ninstitutions and other organizations which, pursuant to written agreements with\nBTG ISRAEL, will undertake to conduct, supervise or participate in a Sponsored\nResearch Program.\n\n     1.7. 'Sponsored Research Program' shall mean a research and development\nprogram which is conducted by BTG ISRAEL or by one or more Research\nInstitution(s) under an agreement with BTG ISRAEL pursuant to the terms and\nconditions of this Agreement.\n\n                                       -2-\n\n\n\n     1.8. 'Technology' shall mean all information and know-how (general and\nspecific) including, without limitation, developments, discoveries, inventions,\nimprovements, designs, methods, processes, techniques, devices, formulae and\ntrade secrets which hereafter are developed, acquired, conceived, result from or\narise in connection with a Sponsored Research Program.\n\n     2. Research and Development Services.\n\n     2.1. From time to time during the term of this Agreement, BTG ISRAEL agrees\nto undertake, at BTG U.S.'s request, Sponsored Research Programs in accordance\nwith the terms of this Agreement. Each such Sponsored Research Program shall be\ninitiated by the submission by BTG U.S. to BTG ISRAEL of a written proposed\nproject plan which shall include:\n\n          (i) the estimated budget for the first year of the Sponsored Research\n     Program; and\n\n          (ii) a proposed development plan setting forth the activities to be\n     carried out, the objectives sought to be achieved, and the projected\n     duration of the Sponsored Research Program.\n\nAny such Sponsored Research Program shall be considered effective and in full\nforce upon written concurrence thereto from an authorized representative of both\nparties. BTG U.S. may make changes to and amend the Sponsored Research Program\nand the project plan from time to time after consulting with BTG ISRAEL.\n\n     BTG ISRAEL hereby agrees to use its best efforts to accomplish the research\ncontemplated by such Sponsored Research Program, directly and\/or by arrangement\nwith Research Institutions, including without limitation expending sufficient\ntime and effort and allocating sufficient staff, but does not guarantee or\nwarrant the results of the Sponsored Research Program.\n\n     2.2. At least ninety (90) days prior to the end of the first year of any\nSponsored Research Program (or any subsequent year if any Sponsored Research\nProgram is extended), BTG ISRAEL and BTG U.S. shall commence good faith\ndiscussions of the budget and any revisions in the project plan with the intent\nof establishing a one-year budget therefor no later than sixty (60) days prior\nto the end of the current year.\n\n     2.3. During the term of this Agreement, BTG ISRAEL shall devote such time\nand effort to the performance of services pursuant to this Agreement as may be\nnecessary or appropriate to fulfill its duties as described in Section 2;\nhowever, it is specifically understood and agreed by BTG U.S. that BTG ISRAEL\nshall not be required to devote full time to such services and that BTG ISRAEL\nshall have the right to engage in its own research and development activities,\nwhich may include research and development activities which may be competitive\nwith the Sponsored Research\n\n                                       -3-\n\n\n\nPrograms and in other business activities with other persons, and BTG U.S. shall\nnot, by virtue of this Agreement, have any right, title or interest in or to\nsuch independent activities or to the income or profits derived therefrom and,\nwithout limiting BTG ISRAEL's obligation to use commercially reasonable efforts\nto provide certain services hereunder, nothing set forth in this Agreement shall\nlimit or reduce the ability of BTG ISRAEL to carry on such other activities.\n\n                  2.4. BTG ISRAEL shall maintain its research and development\nfacilities, and shall conduct its research and development services, in\naccordance with Good Laboratory Practices as required from time to time.\n\n     3. Payment for Services.\n\n     3.1. As compensation for the services to be performed by BTG ISRAEL\nhereunder on behalf of BTG U.S., BTG U.S. agrees to pay to BTG ISRAEL its\nReimbursable Costs incurred in each Sponsored Research Program, all as set forth\nin this Section 3.\n\n     3.2. At the beginning of each fiscal quarter, BTG U.S. shall advance to BTG\nISRAEL one quarter of the total budget for each Sponsored Research Program for\nthe fiscal year or such other amount as indicated in the budget for the\nparticular quarter. Within thirty (30) days after the end of each quarter, BTG\nISRAEL shall furnish to BTG U.S. a written report of its Reimbursable Costs for\neach Sponsored Research Program for that quarter. If the Reimbursable Costs\nexceed the advance, BTG U.S. shall promptly pay the difference to BTG ISRAEL; if\nsuch Reimbursable Costs are less than the advance, such difference shall be\ncredited in U.S. dollars toward the advance for the subsequent fiscal quarter.\nAll revenue received by BTG ISRAEL from pre-commercial sales of products in\naccordance with Section 5 hereof shall be treated as an advance to BTG ISRAEL\npursuant to this Section 3 and shall be credited in U.S. Dollars toward the\nadvance for the subsequent fiscal quarter due BTG ISRAEL pursuant to this\nSection 3.\n\n     BTG ISRAEL shall keep full and true books of account and other records in\nsufficient detail so that the Reimbursable Costs payable to BTG ISRAEL hereunder\ncan be properly ascertained. BTG ISRAEL agrees, at the request of and expense of\nBTG U.S., to permit an independent certified public accountant selected by BTG\nU.S. (except one to whom BTG ISRAEL has some reasonable objection) to have\naccess, once each calendar year, during ordinary business hours, to such books\nand records as may be necessary to determine in respect to invoices for\nReimbursable Costs delivered not more than two (2) years prior to the date of\nsuch request the correctness of any determination of the Reimbursable Costs\ncontained in such invoice, but in no event shall any invoice be reviewed more\nthan once. The basis for any determination of such accountant shall be made\navailable for review and comment by BTG ISRAEL and reconsidered if BTG ISRAEL so\nrequests, and a further determination made at BTG ISRAEL's expense by another\nnationally recognized independent certified public accountant selected by BTG\nU.S. from among three proposed by BTG ISRAEL and such\n\n                                       -4-\n\n\n\naccountant shall make a final determination. Such final determination shall be\nbinding upon the parties hereto.\n\n     3.3. BTG ISRAEL shall use its reasonable best efforts to obtain funding on\nan annual basis for a portion of each Sponsored Research Program from the Chief\nScientist.\n\n     3.4. BTG U.S. shall bear all risks of loss attributable to the research and\ndevelopment activities performed on its behalf by BTG ISRAEL. BTG ISRAEL shall\nbe entitled to retain the entire amount of Reimbursable Costs received pursuant\nto this Section, whether or not the research and development work is successful\nand accomplished the results contemplated by any Sponsored Research Program.\n\n     4. Technical Assistance. BTG ISRAEL agrees to make available to BTG U.S. or\nits designee, at reasonable times and places and on reasonable notice, the\nservices of technical personnel to consult with, instruct and assist BTG U.S. or\nits designee in utilizing the Technology.\n\n     5. Pre-Commercial Sales. BTG ISRAEL shall, at the request of BTG U.S., sell\nproducts to third parties who have obtained license or distribution rights in\nrespect of such products for use by such third parties in conducting clinical\ntests and obtaining regulatory approval to market such products. All amounts\nreceived by BTG ISRAEL in respect of such sales shall, for purposes of this\nAgreement, be treated as advances of payments due BTG ISRAEL hereunder.\n\n     6. Reports and Records.\n\n     6.1. BTG ISRAEL shall furnish BTG U.S. within sixty (60) days of the end of\neach of BTG ISRAEL's fiscal quarters a report in such reasonable detail as BTG\nU.S. may request setting forth:\n\n          (a) the work performed by BTG ISRAEL during such quarter with respect\n     to such Sponsored Research Program; and\n\n          (b) the status of such Sponsored Research Program at the end of such\n     quarter.\n\nIn addition, BTG ISRAEL shall furnish to BTG U.S. such information regarding the\nstatus of the sponsored Research Program as BTG U.S. may from time to time\nreasonably request.\n\n     6.2. Within ninety (90) days after the completion of such Sponsored\nResearch Program, BTG ISRAEL shall provide to BTG U.S. a final report in such\nreasonable detail as BTG U.S. may request setting forth all Reimbursable Costs\nincurred by BTG ISRAEL in connection therewith.\n\n                                       -5-\n\n\n\n     6.3. BTG ISRAEL shall keep complete, accurate and authentic accounts,\nnotes, data and records relating to such Sponsored Research Program in the\nmanner and form approved by BTG U.S. Such accounts, notes, data and records\nshall be available for inspection and copying by BTG U.S. and its authorized\nrepresentative during regular business hours.\n\n     6.4. BTG ISRAEL shall provide to BTG U.S. such data and information\nresulting from its conduct of the Sponsored Research Program and such reasonable\nassistance as BTG U.S. may reasonably require in connection with preparing\napplications required for governmental approval of, and obtaining approval of,\nthe use, marketing and distribution of the product(s) resulting from the\nSponsored Research Program.\n\n     7. Ownership and Patents.\n\n     7.1. BTG U.S. shall have exclusive right, title and interest in and to the\nTechnology, and BTG ISRAEL shall have no rights with respect thereto. The\nparties hereto recognize and agree that BTG ISRAEL is merely rendering research\nand development services to BTG U.S., and that BTG U.S. is the developer of the\nTechnology.\n\n     Nothing herein is intended to derogate from BTG ISRAEL's ownership of the\nreal property, tools, machinery and equipment acquired by it in furtherance of,\nor incidental to, any Sponsored Research Program, whether or not the research\nand development work is successful and accomplishes the results contemplated by\nany such Sponsored Research Program.\n\n     7.2. Any patent applications or patents for the Technology shall be owned\nby BTG U.S., and BTG ISRAEL shall have no rights with respect thereto. BTG U.S.\nshall have sole control over filing and prosecuting applications for United\nStates and foreign patents covering the Technology and shall file and prosecute\nthe same in BTG U.S.'s name. The cost for all such filings and prosecutions\nshall be borne by BTG U.S. BTG ISRAEL agrees to use its best efforts to cause\neach of its employees and consultants and each Research Institution (and each\nPrincipal Investigator thereat) working on a Sponsored Research Program to enter\ninto a binding written agreement, reasonably acceptable to BTG U.S., to the\neffect that (i) if such person is a sole inventor or joint inventor of\nTechnology, such employee, consultant or Principal Investigator will, without\nfurther compensation, provide BTG U.S. with the necessary authorizations, powers\nof attorney and other documents and assistance reasonably requested by BTG U.S.\nto secure and maintain BTG U.S.'s patent rights in the United States and\/or\nforeign countries and (ii) such person shall safeguard the secrecy and\nconfidentiality of, and the proprietary rights of BTG U.S. in and to, the\nTechnology and any information relating thereto, and to use the Technology and\nany information relating thereto solely in connection with such Sponsored\nResearch Program. BTG ISRAEL will use its reasonable efforts to cause such\nemployee(s), consultant(s),\n\n                                       -6-\n\n\n\nResearch Institution(s) and Principal Investigator(s) to fulfill their\nobligations under such agreements.\n\n     Notwithstanding anything herein to the contrary, the parties acknowledge\nthat under certain agreements previously entered into by BTG ISRAEL with\nResearch Institutions, patent rights with respect to certain Technology are, and\nwill continue to be, owned by such Research Institutions.\n\n     7.3. Within sixty (60) days of (i) delivering a certificate signed by an\nofficer of BTG ISRAEL certifying completion of a Sponsored Research Program or\n(ii) termination of such Sponsored Research Program pursuant to Section 9\nhereof, BTG ISRAEL will transfer and deliver to BTG U.S. all property and\nproperty rights in which BTG U.S. has ownership rights pursuant to Section 7.1\nabove held by or under the control of BTG ISRAEL relating to such Sponsored\nResearch Program.\n\n     8. Disclosure of Information.\n\n     8.1. BTG ISRAEL shall not furnish copies of documents, patents, patent\napplications, copyrights, drawings, specifications, bills of materials, devices,\nequipment, prototypes and other information relating to the Technology other\nthan as contemplated by this Agreement and shall not, without prior written\napproval of BTG U.S., disclose such information to any third party except to the\nextent that such disclosure is necessary to BTG ISRAEL's performance of a\nSponsored Research Program, and then only if (i) such disclosure is subject to\nthe same limitations on the recipient as on BTG ISRAEL, and (ii) such\nlimitations are set forth in a written agreement in form and substance\nsatisfactory to BTG U.S.\n\n     8.2. Unless previously so delivered, within sixty (60) days after the\ntermination of this Agreement for any reason, BTG ISRAEL shall deliver to BTG\nU.S. all information and all other property in which BTG U.S. has ownership\nrights pursuant to Section 7 of this Agreement.\n\n     8.3. No publication with respect to any activity undertaken pursuant to any\nSponsored Research Program shall be made, nor any manuscript submitted for\npublication, without the prior review and written approval of BTG U.S.\n\n     8.4. The parties hereto agree that remedies at law may be inadequate to\nprotect against the breach of this Section 8, and in any case of such a breach\nBTG ISRAEL hereby consents to the granting of injunctive relief, whether\ntemporary, preliminary or final, in favor of BTG U.S. without proof of actual\ndamages.\n\n     8.5. The provisions of this Section 8 shall survive the termination of this\nAgreement notwithstanding the reason for such termination.\n\n     9. Term and Termination.\n\n                                       -7-\n\n\n\n\n\n     9.1. This Agreement shall commence as of the date first written above, and\nshall continue in full force and effect unless terminated pursuant to this\nSection 9.\n\n     9.2. This Agreement shall terminate upon:\n\n          (a) the mutual consent of the parties hereto; or\n\n          (b) a party sending notice to the other party of termination of this\n     Agreement upon the occurrence of any of the following events:\n\n               (i) the other party institutes bankruptcy, insolvency,\n          liquidation or receivership proceedings or proceedings for\n          reorganization under bankruptcy or comparable laws;\n\n               (ii) a petition is filed against the other party for any such\n          proceedings listed in (i) above, the effectiveness of which is not\n          stayed or dismissed within ninety (90) days after the filing thereof;\n\n               (iii) the other party shall make a general assignment for the\n          benefit of creditors; or\n\n               (iv) the other party shall commit any material breach of any of\n          the terms or conditions hereof, and also shall fail to remedy such\n          default or breach within ninety (90) days after receipt of written\n          notice thereof from the other party.\n\n     9.3. Notwithstanding the termination of this Agreement as provided in this\nSection 9, the rights and obligations of the parties under Sections 7 and 8\nhereof shall survive such termination and remain in full force and effect.\n\n     10. Research Institutions and Principal Investigators. BTG ISRAEL may enter\ninto agreements with Research Institutions whereby such institutions and\/or the\nPrincipal Investigators undertake to perform all or any portion of a Sponsored\nResearch Program; provided, however, that (except with prior written approval of\nBTG U.S.) no such agreement shall contain any provision which restricts the\nrights conferred upon BTG U.S. hereunder or diminishes the obligations of BTG\nISRAEL hereunder which would be required to be performed by BTG ISRAEL if no\nsuch agreement had been made. Nothing in this Section 10 is intended to derogate\nfrom the provisions of Section 7.2.\n\n     11. Relationship of the Parties. Nothing in this Agreement or in the\nperformance hereof shall have the effect of making BTG U.S. and BTG ISRAEL\npartners, joint venturers or each other's agents, and neither shall have the\nright to act on behalf of or bind the other except as expressly provided\nhereunder or otherwise expressly agreed in writing, and each party shall\nindemnify and hold harmless the other against and from any liability arising\nfrom any such act by such party. BTG ISRAEL\n\n                                       -8-\n\n\n\nwill render the research and development services provided for herein as an\nindependent contractor.\n\n     12. Headings. All section headings used in this Agreement are solely for\nthe convenience of the parties and shall not affect the meaning or\ninterpretation of the provisions thereof.\n\n     13. Governing Law; Consent to Jurisdiction. This Agreement shall be\ngoverned by and construed in accordance with the laws of the State of New York\n(not including its choice of law principles). The parties hereto submit to the\nexclusive jurisdiction and venue of the Supreme Court of the State of New York\nand the Federal District Court for the Southern District of New York for\npurposes of any legal action arising out of this Agreement.\n\n     14. Entire Agreement. This Agreement constitutes the entire agreement\nbetween the parties with respect to the subject matter hereof and supersedes and\nreplaces all prior agreements, understandings, writings and discussions between\nthe parties, including without limitation that certain Research and Development\nServices Agreement, dated as of May 9, 1983.\n\n     15. Amendment; Nonwaiver. This Agreement, and any of the terms hereof,\nshall not be modified, amended or waived except by a written instrument executed\nby the parties or, in the case of a waiver, by the waiving party. The failure of\neither party at any time to require performance of any term hereof shall not\naffect its right at a later time to enforce such term. The waiver by either\nparty of any condition or term hereof in any one or more instances shall not be\nconstrued as a further or continuing waiver of such condition or term.\n\n     16. Unenforceable Provision. If any provision of this Agreement is, or\nbecomes or is deemed to be invalid, illegal or unenforceable in any respect in\nany jurisdiction, such provision shall be deemed amended to conform to\napplicable laws so as to be valid and enforceable or, if it cannot be so amended\nwithout materially altering the intention of the parties, it shall be stricken\nand the remainder of this Agreement shall remain in full force and effect.\n\n     In case any one or more of the provisions contained in this Agreement shall\nbe held invalid, illegal or unenforceable in any respect in any jurisdiction,\nthe validity, legality and enforceability of such provision or provisions shall\nnot in any way be affected or impaired thereby in any other jurisdiction; and\nthe validity, legality and enforceability of the remaining provisions contained\nherein shall not in any way be otherwise affected or impaired thereby.\n\n     17. Notices. All notices and other communications required or desired to be\ngiven or sent by one party to the other party shall be in writing, in the\nEnglish language, and shall be deemed to have been given (a) on the date of\ndelivery, if delivered to the persons identified below, (b) five calendar days\nafter mailing if mailed,\n\n                                       -9-\n\n\n\n\n\nwith proper postage, by certified or registered airmail, postage prepaid, return\nreceipt requested, addressed as set forth below, (c) on the date of receipt if\nsent by telex or telecopy, and confirmed in writing in the manner set forth in\n(b) on or before the next day after the sending of the telex or telecopy, or (d)\ntwo business days after delivered to an internationally recognized overnight\ncourier service marked for overnight delivery, as follows:\n\n     To BTG U.S.:                Bio-Technology General Corp.\n                                 70 Wood Avenue South\n                                 Iselin, New Jersey 08830\n                                 Attn:  President\n                                 Telecopier:  908-632-8844\n\n     To BTG ISRAEL:              Bio-Technology General (Israel) Ltd.\n                                 Kiryat Weizmann\n                                 Rehovot 76326, Israel\n                                 Attn:  President\n                                 Telecopier:  972-8-409041\n\n     Any party may change such party's address for notices by notice duly given\npursuant to this Section 17.\n\n     18. Assignment. Neither this Agreement nor any right or obligation arising\nhereunder may be assigned by BTG ISRAEL in whole or in part, without the prior\nwritten consent of BTG U.S., which consent may be withheld in the absolute\ndiscretion of BTG U.S. BTG U.S. may, upon written notice to BTG ISRAEL, assign\nthis Agreement or any part hereof without the prior consent of BTG ISRAEL,\nsubject to any limitation imposed by any agreement (approved by BTG U.S.) to\nwhich BTG ISRAEL is a party. This Agreement shall be binding upon any assignee\nand, subject to the restrictions on assignment herein set forth, inure to the\nbenefit of the successors and assigns of each of the parties hereto.\n\n     19. Counterparts. This Agreement may be executed in one or more\ncounterparts, each of which shall be deemed an original; but such counterparts\nshall together constitute but one and the same instrument.\n\n                                      -10-\n\n\n\n\n     IN WITNESS WHEREOF, the parties have executed this Agreement as of the date\nfirst set forth above.\n\n\n                         BIO-TECHNOLOGY GENERAL CORP.\n\n                         By:_____________________________________\n\n                         Title:__________________________________\n\n\n                         BIO-TECHNOLOGY GENERAL (ISRAEL) LTD.\n\n\n                         By:_____________________________________\n\n                         Title:__________________________________\n\n\n                                      -11-\n<\/pre>\n","protected":false},"template":"","meta":{"_acf_changed":false,"_stopmodifiedupdate":true,"_modified_date":"","_cloudinary_featured_overwrite":false},"corporate_contracts_companies":[6900],"corporate_contracts_industries":[9406],"corporate_contracts_types":[9613,9620],"class_list":["post-42735","corporate_contracts","type-corporate_contracts","status-publish","hentry","corporate_contracts_companies-bio-technology-general-corp","corporate_contracts_industries-drugs__botanical","corporate_contracts_types-operations","corporate_contracts_types-operations__services"],"acf":[],"_links":{"self":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts\/42735","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts"}],"about":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/types\/corporate_contracts"}],"wp:attachment":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/media?parent=42735"}],"wp:term":[{"taxonomy":"corporate_contracts_companies","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_companies?post=42735"},{"taxonomy":"corporate_contracts_industries","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_industries?post=42735"},{"taxonomy":"corporate_contracts_types","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_types?post=42735"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}